What does TCAR (TransCarotid Artery Revascularization) stand for in relation to carotid stenting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

TCAR Definition in Carotid Stenting

TCAR stands for TransCarotid Artery Revascularization, a minimally invasive hybrid technique for treating carotid artery stenosis that uses direct common carotid artery access combined with dynamic flow reversal technology 1.

What TCAR Is

TCAR is a carotid stenting procedure that entirely bypasses the aortic arch by accessing the carotid artery directly through a small incision in the neck 1. The defining feature is the use of "dynamic flow reversal"—blood flow is temporarily reversed during the procedure to redirect any embolic debris away from the brain and into the femoral vein, thereby minimizing stroke risk during stent placement 1.

Key Technical Characteristics

The procedure involves:

  • Direct surgical access to the common carotid artery (not percutaneous puncture as in traditional transfemoral CAS)
  • Flow reversal system that serves as the primary mechanism of procedural stroke reduction 1
  • Avoidance of aortic arch manipulation, eliminating cerebral embolism from arch cannulation 1
  • Typically completed in less than 1 hour of operative time 2

Clinical Context and Position

TCAR emerged as an alternative to both carotid endarterectomy (CEA) and transfemoral carotid artery stenting (tfCAS) 3. According to the 2025 ESC consensus statement, TCAR has gained particular popularity in the USA since its commercial introduction in 2015 1, 4.

Current Evidence Status

The 2025 ESC guidelines note that lack of prospective randomized evidence with independent neurological assessments currently precludes routine recommendation for TCAR over CEA in symptomatic patients 1. However, registry data from the VQI TCAR Surveillance Project suggest TCAR may be associated with lower stroke/death risk compared to 1st generation stent tfCAS and similar rates to CEA 1.

Specific Indications Where TCAR Shows Promise

TCAR has potential as preferred treatment in higher-risk patients with specific clinical or anatomic factors 1:

  • High carotid lesions (extending cranially to C2 vertebra)
  • Cervical spine immobility
  • Post-CEA restenosis
  • Prior neck irradiation
  • "Hostile neck" anatomy
  • Severe aortic or femoral artery pathology 1

Important Anatomical Requirements

TCAR has specific anatomical prerequisites that limit its universal applicability 1:

  • Disease-free common carotid artery at the puncture site
  • ≥5 cm distance between clavicle and carotid bifurcation
  • Minimal to no atherosclerosis at the common carotid artery access point 1

Comparative Outcomes

Recent meta-analysis data (2026) demonstrate that TCAR is associated with 5:

  • Significantly reduced 30-day mortality (RR 0.45; P < 0.001)
  • Lower 30-day stroke rates (RR 0.66; P < 0.001)
  • Reduced composite stroke/death (RR 0.57; P < 0.001)
  • Lower TIA rates compared to tfCAS

However, a 2025 propensity-matched analysis found that with 1st generation stents, symptomatic patients had similar 1-year ipsilateral stroke or death between TCAR and tfCAS (HR 0.99; 95% CI 0.74–1.32) 1.

Current Limitations

Important caveats include 1:

  • Most TCAR data comes from registries, not randomized trials
  • Patient populations in TCAR studies may differ from CEA/tfCAS studies
  • European real-world data (340 patients) failed to confirm advantages of transcervical approach 1
  • TCAR is viewed in Europe as promising but requiring RCT validation before recommending as CEA alternative 1

The technique represents an evolving option in the carotid revascularization armamentarium, with ongoing need for robust comparative trials 1, 3.

Related Questions

In an 84‑year‑old man with hypertension, hyperlipidemia, recent transient ischemic attack (TIA) after transcarotid artery revascularization (TCAR), bilateral carotid stenosis, benign prostatic hyperplasia (BPH), chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) ≈56 mL/min, atrial fibrillation, coronary artery disease, and a history of nicotine dependence who now has hyperkalaemia and mild metabolic acidosis, what is the recommended management of his laboratory abnormalities?
What is the recommended anesthesia management for transcarotid artery revascularization (TCAR)?
What are the anatomic criteria for transcarotid artery revascularization (TCAR)?
What are the criteria for selecting carotid endarterectomy versus carotid artery stenting and the recommended medical therapy for patients with significant carotid stenosis?
What are the benefits of influenza (flu) and respiratory syncytial virus (RSV) vaccination in elderly patients (age ≥ 65 years)?
In a patient with resolved hepatitis B infection and documented immunity (HBsAg negative, anti‑HBc IgG positive, anti‑HBs positive), is routine long‑term follow‑up and surveillance laboratory testing required?
Which contraceptive method provides the highest efficacy with minimal side effects, preserves female fertility, and allows rapid return to fertility after 1–2 years of use, given that Implanon (etonogestrel implant) causes irregular/heavy bleeding, combined oral contraceptives cannot be used long term, depot medroxyprogesterone acetate (DMPA) causes osteoporosis and amenorrhea, and the levonorgestrel intrauterine system (Mirena) causes irregular/heavy bleeding?
What is the appropriate workup for an elderly patient with unintentional acute weight loss over three months?
Can berberine be used as an adjunctive therapy for type 2 diabetes in adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.